HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma-Reference-Cited by-同舟云学术

HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma

Published:2018-12-14 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lamberti Dante¹,Cristinziano Giulia¹,Porru Manuela²,Leonetti Carlo²,Egan Jan B.³,Shi Chang‐Xin³,Buglioni Simonetta⁴,Amoreo Carla A.⁴,Castellani Loriana⁵⁶,Borad Mitesh J.³,Alemà Stefano⁶,Anastasi Sergio¹,Segatto Oreste¹

Affiliation:

1. Unit of Oncogenomics and Epigenetics IRCCS Regina Elena National Cancer Institute Rome Italy

2. Animal Facility (SAFU) IRCCS Regina Elena National Cancer Institute Rome Italy

3. Division of Hematology and Oncology Mayo Clinic Scottsdale Arizona

4. Department of Pathology IRCCS Regina Elena National Cancer Institute Rome Italy

5. Dipartimento di Scienze Umane, Sociali e della Salute Università di Cassino Cassino Italy

6. Institute of Cell Biology and Neurobiology National Research Council (CNR) Monterotondo Italy

Funder

Verein fur Krebsforschung

Consejería de Economía y Hacienda

National Research Council Sri Lanka

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30127

Reference29 articles.

1. Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction;Carter EP;Trends Cell Biol,2015

2. Identification of targetable FGFR gene fusions in diverse cancers;Wu YM;Cancer Discov,2013

3. New horizons for precision medicine in biliary tract cancers;Valle JW;Cancer Discov,2017

4. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma;Graham RP;Hum Pathol,2014

5. Massive parallel sequencing uncovers actionable FGFR2‐PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma;Sia D;Nat Commun,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a bioinformatics-based prognostic model related to liquid-liquid phase separation in lung adenocarcinoma;2024-01-10

2. Current Status and Progress of Systemic and Local Therapy for Intrahepatic Cholangiocarcinoma;Advances in Clinical Medicine;2024

3. Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma;Cancer Treatment Reviews;2023-12

4. FGFR families: biological functions and therapeutic interventions in tumors;MedComm;2023-09-23

5. Driving the degradation of oncofusion proteins for targeted cancer therapy;Drug Discovery Today;2023-06